GEISINGER MEDICAL CENTER — History
CCN 390006 | 3-year financial timeline | COVID resilience: 53/100
🛡️ Public data only — no PHI permitted on this instance.
$1.6B
Latest Revenue (FY2022)
+7.0%
Revenue CAGR (3yr)
4.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $1.4B | $1.5B | $1.6B | +7.6% | +7.0% |
| Operating Expenses | $1.3B | $1.4B | $1.5B | +4.8% | +9.0% |
| Operating Margin | 7.6% | 1.6% | 4.1% | +155.6% | -26.1% |
| Net Income | $105M | $24M | $65M | +175.0% | -21.0% |
| Licensed Beds | 526 | 525 | 525 | +0.0% | -0.1% |
| Total Patient Days | 151,253 | 162,393 | 154,762 | -4.7% | +1.2% |
| Medicare Day % | 26% | 24% | 23% | -4.5% | -5.3% |
| Medicaid Day % | 4% | 3% | 3% | +0.8% | -10.2% |
COVID Impact & Recovery
Resilience Score: 53/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +14.5% ($1.4B → $1.6B)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.0%
This Hospital
+7.6%
State Avg
Latest Margin
4.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $1.7B | 2.4% |
| FY2024 (proj) | $1.8B | 0.7% |
| FY2025 (proj) | $1.9B | -1.0% |